Mara Inniss

Company: Obsidian Therapeutics

Job title: Director

Seminars:

Developing Gene Editing Therapies That Utilize Obsidian’s cytoDRiVE™ Platform to Provide Regulated & Tunable Expression of Proteins 2:30 pm

• Modulating the activity of gene editing tools like CRISPR-Cas9 to increase the specificity and reduce off-target effects • Determining the best small-molecule regulators to use with the platform and validating the system in various preclinical models • Demonstrating proof of concept for the ability to modulate gene editing activities in a controlled and precise…Read more

day: Day 1- Translation 2